Search

Author/Creator Beyett, Tyler S.

1. Design, synthesis, and biological activity of substituted 2-amino-5-oxo-5H-chromeno[2, 3-b]pyridine-3-carboxylic acid derivatives as inhibitors of the inflammatory kinases TBK1 and IKKε for the treatment of obesity. Issue 20 (1st November 2018)

Authors:
Beyett, Tyler S.; Gan, Xinmin; Reilly, Shannon M.; Gomez, Andrew V.; Chang, Louise; Tesmer, John J.G.; Saltiel, Alan R.; Showalter, Hollis D.
Journal:
Bioorganic & medicinal chemistry
Issue:
Volume 26:Issue 20(2018)
Page Start:
5443
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Quinazolinones as allosteric fourth-generation EGFR inhibitors for the treatment of NSCLC. (15th July 2022)

Authors:
Gero, Thomas W.; Heppner, David E.; Beyett, Tyler S.; To, Ciric; Azevedo, Seth C.; Jang, Jaebong; Bunnell, Thomas; Feru, Frederic; Li, Zhengnian; Shin, Bo Hee; Soroko, Kara M.; Gokhale, Prafulla C.; Gray, Nathanael S.; Jänne, Pasi A.; Eck, Michael J.; Scott, David A.
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 68(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Synthesis of deuterium‐labelled amlexanox and its metabolic stability against mouse, rat, and human microsomes. (3rd April 2019)

Authors:
Gan, Xinmin; Wilson, Michael W.; Beyett, Tyler S.; Wen, Bo; Sun, Duxin; Larsen, Scott D.; Tesmer, John J.G.; Saltiel, Alan R.; Showalter, Hollis D.
Journal:
Journal of labelled compounds & radiopharmaceuticals
Issue:
Volume 62:Number 5(2019)
Page Start:
202
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗